Volume Spike Investor

Novavax, Inc. (Nasdaq: NVAX) is soaring on high volume.  The company has manufactured a virus-like particle vaccine candidate against the H1N1 pandemic influenza virus (Swine Flu) under current good-manufacturing practices in the Rockville, MD facilities in only 11 weeks after receiving the gene sequence for the H1N1 strain from the CDC….  Novavax has produced essential [...]

Novavax Inc. (Nasdaq: NVAX) shares are up 2.5 percent to $3.27 on premarket volume of about 180,000 shares just after 9 a.m. Eastern. The company said it has selected a respiratory virus candidate for additional preclinical studies to support an investigational new drug application. The company says the selected vaccine has been shown to protect [...]

Novavax Inc. (Nasdaq: NVAX) shares are up more than 10 percent with nearly 100,000 shares traded in the premarket after the company announced a joint venture in India with Cadila Pharmaceuticals, called CPL Biologicals. The joint venture will focus on vaccines, biological therapeutics and diagnostics. CPL Biologicals also expects to develop the pandemic H1N1 influenza [...]

Shares of vaccine maker Novavax Inc. (Nasdaq: NVAX) are rising in premarket trading, seeing some continued buying a day after Spanish health authorities licensed its technologies to make pandemic and seasonal flu vaccines. The stock had risen more than 30 percent yesterday on the news. Boutique research firm Rodman and Renshaw raised its target on [...]

Novavax (NVAX) is down over 10% this morning as investors continue to bail out of their speculative swine flu (or any flu and vaccine) stocks. At $2.12 before the bell, this was as high as $3.88 earlier this week.  As of 8:46 we have seen 223,000 shares trade hands. Generex Biotechnology Corp. (GNBT) is also [...]

As you will see below, Novavax, Inc. (NASDAQ: NVAX), Generex Biotechnology Corp. (NASDAQ: GNBT), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Pure Bioscience (NASDAQ: PURE), Vical Inc (NASDAQ: VICL), Meridian Bioscience Inc. (NASDAQ: VIVO), and AVI BioPharma Inc. (NASDAQ: AVII) have all begun their overbought roll-over.  Full analysis can be found at 24/7 Wall Street. Novavax, Inc. [...]

Monday is looking like a SWINE FLU speculative flu stock stock bonanza. The two approved drug treatments, not vaccines, which are being released are Tamiflu made by Roche (OTC: RHHBY) and Relenza made by GlaxoSmithkline (NYSE: GSK).   Gilead Sciences, Inc. (GILD) gets royalties from Roche for Tamiflu, and its shares are indicated north of $48.00 [...]